Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-Controlled Sedation in Port Implantation (PACSPI-2)
NCT05688384Phase 4Completed
- Sponsor
- Region Jönköpings Län
- Start
- Jan 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propofol and alfentanil in procedural pain (2 arms), sponsored by Region Jönköpings Län. Primary endpoint: Maximal intraprocedural pain level on numeric rating scale. Started Jan 2023; status: completed.
02
Drugs
propofolalfentanil
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT05688384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05688384.